Mirtazapine
Product Images NDC 43353-962

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 43353-962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mirtazapine Tablets, Usp 30 mg Bottle Labels (43353 0962 15)

Mirtazapine is a medication manufactured by Mylan Pharmaceuticals Inc. It is composed of 30mg of 15 tablets per package and can be found under the NDC # 43353-0962-15. The medication needs to be stored in temperatures between 2 and 30 degrees Celsius, and it is recommended to be dispensed as directed by a doctor. The packaging also contains information about the manufacturer and repackager.*

FDA Label Image

Mirtazapine Tablets, Usp 15 mg Bottle Labels (43353 0963 60)

This is a description of a medication called Mirtazapine. The medication comes in a bottle with 90 tablets of 15mg each. The NDC number is 43353-0963-60. The medication should be stored between 20-25 degrees Celsius (68-77 degrees Fahrenheit) following the USP standards. The medication was manufactured by Mylan Pharmaceuticals Inc. in Morgantown, WV, and repackaged by Aphena Pharma in Cookeville, TN.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Mirtazapine Stuctural Formula (Image 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.